A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404)
暂无分享,去创建一个
D. Sakai | T. Satoh | T. Tsujinaka | Y. Kurokawa | T. Shimokawa | J. Kawada | T. Kii | H. Kawakami | J. Matsuyama | M. Nomura | M. Hirota | T. Ohta